"MHRA confirms acceptance of UK Marketing Authorisation Application for HMTM"

TauRx's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. We are currently conducting clinical trials.